New Delhi, November 2014 – GlaxoSmithKline Consumer Healthcare registered a 9 per cent increase in its net profit to Rs. 160 crore for the quarter ended September 30, against Rs. 146.93 crore in the corresponding quarter of the last fiscal.
Net sales grew 11 per cent to Rs. 1,075 crore from the same period last fiscal.
Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd, said, “We are delighted to have delivered consistent growth as the category leader.”
“The consumer sentiment is showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category.” He added, “We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base.”
On Wednesday, the company’s stock closed at Rs. 5407.65, down 2.39 per cent, on the BSE. Business Line
